Dulaglutide

CAS NO.: 923950-08-7
Molecular Formula: C2646H4044N704O836S18
Molecular Weight: 59670.63
Appearance: White Powder
Purity: 99.0%

Indications
Suitable for blood sugar control in adults with type 2 diabetes

Function
1. Has renal protection;
2. Can effectively control weight;
3. Has a good cardiovascular protective effect;
4. Inhibit liver glycogenolysis and gluconeogenesis;
5. Extend the time food stays in the stomach;
6. Help the pancreas to release insulin in response to high sugar in the blood after eating;

Description About Dulaglutide
Dulaglutide is one of the hypoglycemic drugs, which can suppress appetite, reduce gastrointestinal peristalsis, and have the effect of hypoglycemic and weight loss.
Dulaglutide is a new type of glucagon-like peptide-1 (GLP-1) analogue, which is produced by DNA recombinant technology and using CHO cells. It can lower blood sugar, improve pancreatic β-cell function, delay gastric emptying and increase pharmacological effects of satiety.
Dulaglutide acts on the GLP-1 receptor, promotes insulin secretion in a glucose concentration-dependent manner, inhibits glucagon secretion, and can delay gastric emptying, reducing food intake through central appetite suppression. In other words, it indirectly promotes insulin secretion and achieves hypoglycemic effects in various ways. Therefore, it also has a certain protective effect on islet cells and can slow down the failure of islet cells.
Dulaglutide is one of the common hypoglycemic drugs. It can effectively stimulate the secretion of insulin, but also has the effect of protecting the kidneys, reducing weight, and benefiting the cardiovascular system. As a new type of hypoglycemic drug, it can significantly improve the body's dependence on glucose, thereby promoting the rapid secretion of insulin, improving the shape of insulin cells, stimulating the continuous reproduction and growth of insulin cells, and finally delaying the emptying of the stomach to achieve hypoglycemic effect.